spacer
home > ebr > spring 2002 > quebec leads the way in canada's biotechnology sector
PUBLICATIONS
European Biopharmaceutical Review

Quebec Leads the Way in Canada's Biotechnology Sector

The biotechnology sector is already well entrenched in Canada and in the Province of Quebec. Its significance in the nation's economy is no longer an issue. Quebec's potential for growth elicits even more hope, as well as intense rivalries. However, although many numbers abound, it is often difficult to draw an accurate statistical portrait of the true situation.

A Few More Specifics

A survey undertaken by Statistics Canada in 1999 on the operations and development of the biotechnology sector measured several industry parameters. The data collected constitutes a reliable indicator of the recent and anticipated evolution of the biotech industry.

Beyond the increase in the number of companies, a considerable amount of data testify to the sector's sustained growth that might even be accelerating. Revenue from biotechnology activities in Canada jumped by 71.6 per cent from 1997 to 1999. In the Province of Quebec, the increase was even more spectacular, soaring more than 147.3 per cent over the same two-year period. This dramatic growth in revenue is a clear sign that the industry has attained a certain maturity. Worldwide, Canadian sales account for less than 5 per cent. However, that figure could double between now and 2005.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Perry Niro, Executive Director at BIOQuebec

A graduate of the University of Montreal, with a Master's degree in Political Science and training in public relations, Perry Niro began his career in 1987 at the Order of Chartered Accountants of Quebec as a Public Affairs Advisor.
In 1990 he was appointed Political Advisor within the Quebec Environment Minister's Office. In 1993 he founded Envirotech magazine which he ran until 1997.
After a stint as Public Affairs Director of the Quebec Industrial Research Association (ADRIQ), he was appointed Executive Director of BIOQuebec - the Quebec Bio-industries Association - in January 2000.

spacer
Perry Niro
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 
Industry Events

BioPharm America™ 2019—12th Annual International Partnering Conference

11-12 September 2019, Boston Convention and Exhibition Center (BCEC), Boston, MA 02210 USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. BioPharm America annually attracts 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement